Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge

This study explores a dual expression vector system for delivering prokaryotic and eukaryotic antigens to improve conventional vaccination strategies. To enhance immune protection against H9N2 avian influenza virus (AIV), which threatens poultry and humans, we used the previously constructed pJHL270...

Full description

Saved in:
Bibliographic Details
Main Authors: Ram Prasad Aganja, In-Shik Kim, Hyun-Jin Tae, John Hwa Lee
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Poultry Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0032579124011805
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591816889729024
author Ram Prasad Aganja
In-Shik Kim
Hyun-Jin Tae
John Hwa Lee
author_facet Ram Prasad Aganja
In-Shik Kim
Hyun-Jin Tae
John Hwa Lee
author_sort Ram Prasad Aganja
collection DOAJ
description This study explores a dual expression vector system for delivering prokaryotic and eukaryotic antigens to improve conventional vaccination strategies. To enhance immune protection against H9N2 avian influenza virus (AIV), which threatens poultry and humans, we used the previously constructed pJHL270 and pJHL305 plasmids with the Ptrc and CMV promoters to stimulate MHC class II and I responses through exogenous and endogenous antigenic presentation. Salmonella Gallinarum (SG), a delivery vector, was engineered to have defective lipopolysaccharide structures through lon, pagL, and rfaL deletion. It demonstrated a safety profile with lower induction of inflammatory cytokines than the wild-type strain. Bioinformatics tools predicted that the HA1 and M2e sequences, which were designed as consensus sequences of South Korean strains (2000–2021), would have high antigenicity and favorable structures. In vitro expression of the vaccine constructs was validated by western blotting. Birds immunized with attenuated SG harboring pJHL270 (JOL3025) or pJHL305 (JOL3027) containing HA-M2e showed significant increases in serum IgY and mucosal IgA antibodies, indicating strong humoral and mucosal immune responses, comparable with inactivated commercial vaccine. Post-immunization, we found a substantial rise in the hemagglutination inhibition titer, suggesting effective prevention of viral attachment and robust cell-mediated immunity, with a 1.96-fold and 2.80-fold increase in CD4+ and CD8+ T cells, respectively, for JOL3025 and a 1.75-fold and 2.49-fold increase for JOL3027. Furthermore, MHC class I and II expression increased 1.35-fold and 1.63-fold, for JOL3025, and 1.61-fold and 1.68-fold, respectively, for JOL3027. The IL-4 and IFN-γ levels were elevated, indicating a balanced Th-1 and Th-2 response. Post-challenge, birds immunized with vaccine candidates or the commercial vaccine exhibited minimal to no clinical signs, reduced lesions, lower lung viral titers, and negligible impacts on egg production compared to controls. In conclusion, both plasmids successfully delivered HA1-M2e immunogens through the engineered SG strains, eliciting strong humoral, mucosal, and cell-mediated immune responses and co-stimulating MHC class I and II antigen presentation pathways to provide effective protection against H9N2 AIV with minimal adverse effects.
format Article
id doaj-art-07b4a9ba90b346f0a6c7cdcaf563f4e5
institution Kabale University
issn 0032-5791
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Poultry Science
spelling doaj-art-07b4a9ba90b346f0a6c7cdcaf563f4e52025-01-22T05:40:39ZengElsevierPoultry Science0032-57912025-01-011041104602Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challengeRam Prasad Aganja0In-Shik Kim1Hyun-Jin Tae2John Hwa Lee3College of Veterinary Medicine, Jeonbuk National University, Iksan Campus, Iksan 54596, Republic of Korea; College of Veterinary Medicine and Institute of Animal Transplantation, Jeonbuk National University, Campus, Iksan 54596, Republic of KoreaCollege of Veterinary Medicine and Institute of Animal Transplantation, Jeonbuk National University, Campus, Iksan 54596, Republic of KoreaCollege of Veterinary Medicine and Institute of Animal Transplantation, Jeonbuk National University, Campus, Iksan 54596, Republic of KoreaCollege of Veterinary Medicine, Jeonbuk National University, Iksan Campus, Iksan 54596, Republic of Korea; College of Veterinary Medicine and Institute of Animal Transplantation, Jeonbuk National University, Campus, Iksan 54596, Republic of Korea; Corresponding author.This study explores a dual expression vector system for delivering prokaryotic and eukaryotic antigens to improve conventional vaccination strategies. To enhance immune protection against H9N2 avian influenza virus (AIV), which threatens poultry and humans, we used the previously constructed pJHL270 and pJHL305 plasmids with the Ptrc and CMV promoters to stimulate MHC class II and I responses through exogenous and endogenous antigenic presentation. Salmonella Gallinarum (SG), a delivery vector, was engineered to have defective lipopolysaccharide structures through lon, pagL, and rfaL deletion. It demonstrated a safety profile with lower induction of inflammatory cytokines than the wild-type strain. Bioinformatics tools predicted that the HA1 and M2e sequences, which were designed as consensus sequences of South Korean strains (2000–2021), would have high antigenicity and favorable structures. In vitro expression of the vaccine constructs was validated by western blotting. Birds immunized with attenuated SG harboring pJHL270 (JOL3025) or pJHL305 (JOL3027) containing HA-M2e showed significant increases in serum IgY and mucosal IgA antibodies, indicating strong humoral and mucosal immune responses, comparable with inactivated commercial vaccine. Post-immunization, we found a substantial rise in the hemagglutination inhibition titer, suggesting effective prevention of viral attachment and robust cell-mediated immunity, with a 1.96-fold and 2.80-fold increase in CD4+ and CD8+ T cells, respectively, for JOL3025 and a 1.75-fold and 2.49-fold increase for JOL3027. Furthermore, MHC class I and II expression increased 1.35-fold and 1.63-fold, for JOL3025, and 1.61-fold and 1.68-fold, respectively, for JOL3027. The IL-4 and IFN-γ levels were elevated, indicating a balanced Th-1 and Th-2 response. Post-challenge, birds immunized with vaccine candidates or the commercial vaccine exhibited minimal to no clinical signs, reduced lesions, lower lung viral titers, and negligible impacts on egg production compared to controls. In conclusion, both plasmids successfully delivered HA1-M2e immunogens through the engineered SG strains, eliciting strong humoral, mucosal, and cell-mediated immune responses and co-stimulating MHC class I and II antigen presentation pathways to provide effective protection against H9N2 AIV with minimal adverse effects.http://www.sciencedirect.com/science/article/pii/S0032579124011805H9N2Dual expression systemSalmonellaViral titerCell-Mediated response
spellingShingle Ram Prasad Aganja
In-Shik Kim
Hyun-Jin Tae
John Hwa Lee
Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge
Poultry Science
H9N2
Dual expression system
Salmonella
Viral titer
Cell-Mediated response
title Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge
title_full Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge
title_fullStr Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge
title_full_unstemmed Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge
title_short Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge
title_sort expression and delivery of ha1 m2e antigen using an innovative attenuated salmonella mediated delivery system confers promising protection against h9n2 avian influenza challenge
topic H9N2
Dual expression system
Salmonella
Viral titer
Cell-Mediated response
url http://www.sciencedirect.com/science/article/pii/S0032579124011805
work_keys_str_mv AT ramprasadaganja expressionanddeliveryofha1m2eantigenusinganinnovativeattenuatedsalmonellamediateddeliverysystemconferspromisingprotectionagainsth9n2avianinfluenzachallenge
AT inshikkim expressionanddeliveryofha1m2eantigenusinganinnovativeattenuatedsalmonellamediateddeliverysystemconferspromisingprotectionagainsth9n2avianinfluenzachallenge
AT hyunjintae expressionanddeliveryofha1m2eantigenusinganinnovativeattenuatedsalmonellamediateddeliverysystemconferspromisingprotectionagainsth9n2avianinfluenzachallenge
AT johnhwalee expressionanddeliveryofha1m2eantigenusinganinnovativeattenuatedsalmonellamediateddeliverysystemconferspromisingprotectionagainsth9n2avianinfluenzachallenge